IP Library › Granted Patent US 12,188,182
Granted Patent B2
US 12,188,182 · App. 18/530,474 · Granted Jan 7, 2025

Durable and dispersible creped multi-ply tissue

Inventors: Kevin Joseph Vogt (Neenah, WI); Mark William Sachs (Appleton, WI); Erin Ann McCormick (Neenah, WI); Devon Gaynelle Curley (Menasha, WI); Sara Jane Wille Stabelfeldt (Appleton, WI); Nathan John Vogel (Neenah, WI); Christopher Steven LeCount (Greenville, WI)
Assignee: Kimberly-Clark Worldwide, Inc.
D21H27/40A47K10/16B31F1/12D21H27/005B31F1/07B31F1/126B31F2201/0715B31F2201/0764
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,188,182
App. No.
18/530,474
Granted
Jan 7, 2025
Kind
B2
Abstract

The multi-ply tissue products that are both durable and dispersible may be manufactured using a creping process that employs a non-crosslinked vinyl acetate-ethylene polymer as a creping agent. The products generally have a Slosh time less than 2 minutes, such as less than about 60 seconds, such as less than about 45 seconds. Surprisingly, the foregoing Slosh times are achieved despite the tissue products having relatively high cross-machine direction (CD) wet tensile strength, such as greater than about 100 g/3″. Typically, increasing wet tensile strength, particularly wet CD tensile strength, negatively effects dispersability and increases Slosh time. Despite this trend, the multi-ply tissue products have a relatively high degree of wet strength and good dispersability.

Claims (26)

1. A method of manufacturing a multi-ply, creped and embossed tissue product comprising the steps of:

a. providing a first tissue web having a first outer surface and a second outer surface;

b. providing a heated creping surface;

c. applying a latex emulsion comprising a non-crosslinked vinyl acetate-ethylene polymer to at least the first outer surface of the first tissue web to yield a latex treated tissue web;

d. adhering the latex treated tissue web to the heated creping surface;

e. contacting the adhered tissue web with a creping blade to remove the adhered tissue web from the heated creping surface and yield a creped tissue ply;

f. conveying two or more creped tissue plies through an embossing-laminating device to yield a multi-ply, creped and embossed tissue product having a geometric mean tensile strength (GMT) from 700 to 1,700 g/3″, a Durability Index from 10.0 to 18.0 and a Slosh time from 10 seconds to 2 minutes.

2. The method of claim 1 further comprising the step of applying a softening composition to the outer surface of at least one creped tissue ply, wherein the softening composition is selected from the group consisting of a polyhydroxy compound having a molecular weight of at least about 1,000 g/mol, a diamidoamine quaternary compound, an ester quaternary compound, an alkoxy alkyl quaternary compound, a benzyl quaternary compound, an alkyl quaternary compound, an imidazolinium quaternary compounds, a polysiloxane and glycerin.

3. The method of claim 1 wherein the latex emulsion further an anti-blocking agent selected, from the group consisting of surfactants, silicones, waxes and polysaccharides.

4. The method of claim 1 further comprising the step of spirally winding the multi-ply, creped and embossed tissue product around a core to yield a rolled tissue product.

5. The method of claim 1 wherein the first tissue web consists essentially of wood pulp fibers.

6. The method of claim 1 wherein the first tissue web has a basis weight ranging from about 10 to about 30 grams per square meter (gsm).

7. The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a wet CD tensile from about 110 to about 160 g/3″.

8. The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a Wet/Dry Ratio from about 0.10 to about 0.15.

9. The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a Durability Index from 15.0 to 18.0.

10. The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a Stiffness Index from 4.0 to 6.0.

11. The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a Slosh time from about 15 to about 45 seconds.

12. The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a wet burst strength from 150 to 200 gf.

13. The method of claim 1 wherein the latex emulsion is applied to the first tissue web by gravure printing, spraying, flexographic printing or ink jet printing.

14. The method of claim 1 wherein the latex emulsion is applied to the first tissue web in a pattern.

15. The method of claim 14 wherein the pattern is a continuous pattern.

16. The method of claim 14 wherein the pattern comprises a plurality of discrete dots.

17. The method of claim 16 wherein the density of discrete dots ranges from about 25 to about 35 dots per square inch (25.4 mm 2 ) of tissue web surface area.

18. The method of claim 14 wherein the pattern is a continuous reticulated pattern.

19. The method of claim 1 wherein the latex emulsion comprises a non-carboxylated latex emulsion.

20. The method of claim 1 wherein the latex emulsion comprises a carboxyl-functional latex emulsion polymer.

Continuity (5)
Continuation 18136389 · Apr 19, 2023
Continuation 17749318 · May 20, 2022
Continuation 17417184
Provisional Application 62825895 · Mar 29, 2019
Related Publication 20240141593A1 · May 2, 2024
References Cited (58)
US 4063995A · Grossman · 1977 [cited by applicant]
US 4886579A · Clark et al. · 1989 [cited by applicant]
US 8282776B2 · Smith et al. · 2012 [cited by applicant]
US 9121137B2 · Viazmensky et al. · 2015 [cited by applicant]
US 9951477B2 · Zwick et al. · 2018 [cited by applicant]
US 10132041B2 · Hermans et al. · 2018 [cited by applicant]
US 10145069B2 · Shannon et al. · 2018 [cited by applicant]
US 10337148B2 · Rouse et al. · 2019 [cited by applicant]
US 10337149B2 · Rouse et al. · 2019 [cited by applicant]
US 10385516B2 · Zawadzki et al. · 2019 [cited by applicant]
US 10428465B2 · Rouse et al. · 2019 [cited by applicant]
US 10487452B1 · Qin et al. · 2019 [cited by applicant]
US 10550522B2 · Shannon et al. · 2020 [cited by applicant]
US 10753046B2 · Zawadzki et al. · 2020 [cited by applicant]
US 10947673B2 · Rouse et al. · 2021 [cited by applicant]
US 11053643B2 · Rouse et al. · 2021 [cited by applicant]
US 11371191B2 · Vogt et al. · 2022 [cited by applicant]
US 11427968B2 · Vogt et al. · 2022 [cited by applicant]
US 11661707B2 · Vogt · 2023 [cited by examiner]
US 11773538B2 · Vogt et al. · 2023 [cited by applicant]
US 11885073B2 · Vogt · 2024 [cited by examiner]
US 11905665B2 · Tirimacco · 2024 [cited by examiner]
US 20070144697A1 · Dyer et al. · 2007 [cited by applicant]
US 20080073045A1 · Dyer et al. · 2008 [cited by applicant]
US 20140050890A1 · Zwick et al. · 2014 [cited by applicant]
US 20140178660A1 · Kim et al. · 2014 [cited by applicant]
US 20160097163A1 · Rekoske et al. · 2016 [cited by applicant]
US 20160145809A1 · Hermans et al. · 2016 [cited by applicant]
US 20180016749A1 · Zawadzki et al. · 2018 [cited by applicant]
US 20180142419A1 · Rouse et al. · 2018 [cited by applicant]
US 20180142421A1 · Rouse et al. · 2018 [cited by applicant]
US 20190309482A1 · Zawadzki et al. · 2019 [cited by applicant]
US 20200032456A1 · Paulson et al. · 2020 [cited by applicant]
US 20200035456A1 · Fan et al. · 2020 [cited by applicant]
US 20200102705A1 · Rouse et al. · 2020 [cited by applicant]
US 20200115853A1 · Shannon et al. · 2020 [cited by applicant]
US 20210156093A1 · Rouse et al. · 2021 [cited by applicant]
US 20210238806A1 · Tirimacco · 2021 [cited by applicant]
US 20210277603A1 · Anderson et al. · 2021 [cited by applicant]
US 20210285159A1 · Burazin et al. · 2021 [cited by applicant]
US 20210292973A1 · Rouse et al. · 2021 [cited by applicant]
US 20220042248A1 · Vogt et al. · 2022 [cited by applicant]
US 20220090321A1 · Weisman et al. · 2022 [cited by applicant]
US 20220178079A1 · Tirimacco et al. · 2022 [cited by applicant]
US 20220228322A1 · Vogt et al. · 2022 [cited by applicant]
US 20220282428A1 · Vogt et al. · 2022 [cited by applicant]
US 20220287924A1 · Monson et al. · 2022 [cited by applicant]
US 20220332085A1 · Monson et al. · 2022 [cited by applicant]
US 20220364310A1 · Vogt et al. · 2022 [cited by applicant]
US 20240003093A1 · Vogt et al. · 2024 [cited by applicant]
US 20240141593A1 · Vogt · 2024 [cited by examiner]
KR 101794487B1 · 2017 [cited by applicant]
WO 2005113895A1 · 2005 [cited by applicant]
WO 2016122477A1 · 2016 [cited by applicant]
WO 2020205524A1 · 2020 [cited by applicant]
WO 2020247205A1 · 2020 [cited by applicant]
WO 2021194504A1 · 2021 [cited by applicant]
WO 2021194505A1 · 2021 [cited by applicant]